chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Painful arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Body temperature: 101 (High) 101 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was on unspecified blood pressure medication.
Fever, severe muscle pain, severe joint pain, chills, cold sweats, nausea and diarrhea. Symptoms started around 8 pm the day of my vaccine and lasted until around 10 pm in January 27th, 2021
flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Patient states that she started with a headache and fatigue the day after being vaccinated, but then slowly started to have pain and inflammation down her spine. The headache and fatigue resolved after 2 days, but the pain down her back became severe after a couple of days and is still getting worse each day. She states that she also has swelling down the center of her back. She has been alternating acetaminophen and ibuprofen around the clock for several days. In the past day or so, the patient has started to experience pain and swelling in her joints as well. She states that she has had issues with arthritis in her spine and joints in the past but that it has been well controlled for a long time. I recommended that the patient contact her primary care provider to be evaluated. She states that the pain has become so severe that she's having difficulty sleeping and completing daily tasks.
positive for COVID on 8/23; took monoclonal antibodies on 8/25 and dc'd to home; presented to ED 8/27 with SOB, chills, fever, poor appetite, diarrhea x5days, generalized weakness; acute respiratory failure
Vomiting next day. breast pain/nipple pain & hardening the full next week, left foot exploded in "athletes foot" like rash. Followed by burning and pain sensation in Right foot. Entire body aches/pain and Charlie horse like sensation throughout entire body, insomnia, muscle spasms, twitching, rash over arms, legs, feet, belly and hands. Used, heat, ice, tylenal, ibuprophen, massage therapy, stretching, sleep aids, stopped Phentermine, low dose muscle relaxer, antibiotic as tested positive for acetobacter bacterial infection, Steroid cream for rash on arms, tested for Lyme's, tick borne, and Lupus- all clear. Saw Endocrinologist, Dermatology, ER visit, Infectious Disease, and Pain Specialist.
Rash on my hand; My lip was swollen; This is a spontaneous report from a non-contactable consumer (patient).  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, as single dose on an unknown date (Lot number: not provided) for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient asked that if he/she did have the rash on hand after the first dose and his/her lip was swollen, should he/she take the other one. Event outcome was unknown.  Information on the lot/batch number has been requested.
Low grade fever (100.2), severe cold chills and body aches, head congestion,  and bad headache.
The patient passed away on 11/22/21. There is no clinical evidence to support that the death was caused by the vaccine, but since it meets the definition of reportable we are doing so as required.
Pt given immz on 03/15/02 MMR, DTaP (IM R thigh). Parent did not notice any adverse events to this. No swelling, induration, redness at all but noticed 6 wks ago an indentation in right thigh and no muscle in that area (as of June 14th exam).
ill; feeling "shot down"; high fever; body aches; flu-like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 2023NVX-US-000001216.  A 57-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "ill"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "feeling "shot down""; PYREXIA (non-serious), outcome "unknown", described as "high fever"; PAIN (non-serious), outcome "unknown", described as "body aches"; INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu-like symptoms".  Additional information: It was reported that a patient started treatment on an unreported date with an unreported number of doses (reported as "vaccine series") of Pfizer BioNTech COVID-19 vaccine for COVID-19 vaccination. It was reported the patient became ill after the shots. The patient was feeling "shot down" for 2 days and experienced high fever, body aches, and flu-like symptoms. No further follow-up is anticipated.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
This spontaneous report as received from a pharmacist via a publics representative refers to a pharmacist colleague of unknown age and gender. The reporter stated that a pharmacist colleague administered ZOSTAVAX (Lot # unspecified) (dose, frequency, location and route unspecified) to a patient on an unspecified date and then this administering pharmacist colleague developed shingles a few days later. At the time of report, the outcome of the events was unknown. Additional information has been requested.
pt recv vax & devel poss GBS;hosp the day p/vax w/transient weakness & inability to walk or move from neck down;tx w/steroids & IGG;did not require mechanical ventilation;still not able to walk on own as of 30NOV95 but will be transferred
Patient received her flu shot on 9/20/14 and after receiving the vaccine she fainted.
Post well child check and immunization patient was acting normal. Mom states that at dinner time approx. 7 pm she was sitting in her highchair finished with dinner but still in chair when dad saw her get stiff, go limp and eyes rolled back. He alerted mom that something was wrong. Mom picked her up out of her chair and was trying to keep her attention but she was limp in mom's arm. Mom did note that she was breathing at that time. They live near a fire station so she ran her to the station to see if they could help. Her lips were dusky and had ashen colored skin tones. They put O2 on her and she pinked right up. They called 911 and an ambulance came and took her to the ED. Patient arrived at ED around 750 pm. Patient had a temp of 100.3. Patient was given 136.5 mg of Tylenol. Labs were drawn. Concluded possible febrile seizure or breath holding spell. Patient discharged home to monitor.
2-13 cold symptoms, noted fever(felt warm) not temp taken. 2-20 noted flat rash over most of her body, temp 102, conts. with cold like symptoms and cough. 2-23 rash and fever resolved. Cough conts.
PATIENT HAD SHINGRIX SHOT IN LEFT ARM AT AROUND 10AM.  SHE RETURNED THIS AFTERNOON AROUND 5PM WITH RED SPLOTCHES ON MOSTLY LEFT ARM BUT ALSO HAD ONE ON THE RIGHT ARM.  SHE BELIEVES IT IS FROM THE SHOT. SHE STATES THAT SHE IS VERY SENSITIVE TO VACCINATIONS
The day after vaccination rash appeared on my legs. The following day the rash was all over my legs and arms and my shoulders and left cheek; It was itchy and painful; It was itchy and painful; It was itchy and red; This is a spontaneous report from a contactable consumer (patient). A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0183) via an unspecified route of administration, administered in left arm on 05Jun2021 11:45 (at the age of 29 years old) as dose 1, single for COVID-19 immunization (Workplace clinic). The patient medical history included asthmatic from an unknown date and unknown if ongoing. The patient had no known allergies. The patient was diagnosed with COVID prior vaccination. The patient was tested COVID post vaccination. The patient did not receive other vaccine in four weeks. The patient concomitant medications were not reported. On 06Jun2021 at 19:00, the patient experienced the day after vaccination rash appeared on my legs. The following day the rash was all over my legs and arms and my shoulders and left cheek, it was itchy and painful and it was itchy and red. The patient reported that it was itchy and red for two days and then started to go away. Now it was seventh day after vaccine and the patient still had rash on legs although it seems to be going away on it's own. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included PCR (Nasal swab) on 09Jun2021 which result negative. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
PATIENT PRESENT ABDOMINAL PAIN, NAUSEA, VOMITING AND DIZZINESS AFTER THE ADMINISTRATION OF THE GARDASIL 9 VACCINE AND MENVEO.
Patient came in 10/05/2016 to walmart pharmacy saying that she was given the injection too high on her arm. She had a lot of pain and her arm swollen up and that she has been off of work for the whole week. She went to the doctor the following day. Md said there was no tendon rupture. However, Md assumed it could be because she got the injection too high on her arm. The pharmacist who gave the injection said it was given on the deltoid muscle and that it wasnt too high.
Pt. reports rash, itching at injection site, rash with erythema around edges. Started as small red area  and small knot with tenderness at injection site within a couple of days of injection.  The tenderness and knot resolved, but the rash continued to worsen 13 days after.
bivalent vaccine were stored in refrigerator beyond the 30 day BUD; No adverse event; administered 4 doses of the bivalent vaccine which was beyond the 30 day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 4 doses of the bivalent vaccine which was beyond the 30 day BUD), PRODUCT STORAGE ERROR (bivalent vaccine were stored in refrigerator beyond the 30 day BUD) and NO ADVERSE EVENT (No adverse event) in a 44-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059f22a) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Dose 1) on 31-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (Dose 2) on 23-Apr-2021 and PFIZER BIONTECH COVID-19 VACCINE (Dose 3) on 07-Jan-2022. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 24-Feb-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 24-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 4 doses of the bivalent vaccine which was beyond the 30 day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (bivalent vaccine were stored in refrigerator beyond the 30 day BUD) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 4 doses of the bivalent vaccine which was beyond the 30 day BUD), PRODUCT STORAGE ERROR (bivalent vaccine were stored in refrigerator beyond the 30 day BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (administered 4 doses of the bivalent vaccine which was beyond the 30 day BUD) and PRODUCT STORAGE ERROR (bivalent vaccine were stored in refrigerator beyond the 30 day BUD).    No concomitant medications was reported. The doses given were from 3 different vials with the same lot number. The vials were initially stored in the refrigerator on 21-Jan-2021.  No treatment medications was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-714711, US-MODERNATX, INC.-MOD-2023-714710, US-MODERNATX, INC.-MOD-2023-714730 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2023: Live Significant follow up received: Patient details and Relevant Past Drug History added.Drug information, Case summary updated. On 08-Mar-2023: Live non significant follow up received; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714711:Patient S-S US-MODERNATX, INC.-MOD-2023-714710:Patient A-O US-MODERNATX, INC.-MOD-2023-714730:Patient S-O
Mother noticed a yellowish-green fluorescent colored substance oozing out of patient's neck at the nape.  When she wipes it away, it comes back.  There is no wound at the neck, and no rash, warmth, fever or any other symptoms to note other than irritability and possible headache.  Child was given 3/4 tsp of Motrin because he had red eyes and was "cranky".  Mom said he slept from 7:00Pm to 7:00AM this morning and has just been a little cranky.  Mom took this child along with her daughter to physician today and doctor does not believe that the yellow substance at the neck has anything to do with vaccine.  Conducted an interview with mother today and found that mom gives flintstone vitamins (2 a day) to daughter along with Singulair and son, gets 1/2 flintstone vitamin daily.  Mom gave patient Motrin last night for his irritability, but says that he has not run a fever.  No rash or swelling to report at injection site.  No new cleaning supplies, soaps, detergents, shampoo or toothpaste.
The patient only received 1/2 of Gardasil 9; The vaccine spilled; This spontaneous report was received from a medical assistant reporting about a patient of unknown age and gender. Information about the patient's medical istory, concurrent conditions or concomitant medications was not reported.      On an unknown date, the patient was vaccinated with only half of a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (underdose, incorrect dose administered) for prophylaxis (route, dose number, lot number and expiration date were not reported) because the vaccine "spilled".
Mother of patient called Monday 11-13-06. States child got fever 102 degrees three hours after receiving Fluzone flu vaccine 0.5 ml and bad headache. Still headache next day with fever 101 degrees (11-11-06). On 11-21-06, headache a little better with fever 99-100 degrees.
Patient had diarrhea about an hour after she received the vaccine and she is uncomfortable moving her arm due to soreness.  The soreness has continued until 1/20/2021, she has her arm in a sling.
OUTBREAK OF STYE OR HERPES IN LEFT EYE, OUTBREAK OF SORES IN LEFT BROW...LEFT EYE SORE N RED AND SWOLLEN,..NUMBNESS ABOUE LEFT BROW, FEELS LIKE IT SPREADING TO MY FORE HEAD.
After my first vaccine, I experienced right arm soreness and within 48 hours it went away. Then on day six in the morning, I experienced swelling around the injection site. it was hard, swelling and warm to touch.
First dose / September 22th 2020 / second dose has not been received yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 22nd September 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were received as follows: The age at vaccination was not applicable for this report. The VAERS details were reported for the 1st dose. Till the time of reporting patient did not receive the 2nd dose, which led to incomplete course of vaccination. The reporter did not consent to follow up.
numb lips and tongue, cold like s/s. Narrative:  s/s above onset within 5 mins of shot, never had difficulties breathing or swallowing, VSS. Numbness resolved within 4 hours of injection, cold like s/s continue.
A physician reported the occurrence of an injection site reaction in a female child of unspecified age who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. On 4/22/03, the subject received her fourth injection of Infanrix (lot DTPA572A). On an unspecified date post-immunization, the subject developed an injection site reaction characterized by redness, warmth, and swelling larger than a 50-cent piece. The injection site reaction resolved after an unspecified period of time. The reporter considered the injection site reaction to be probably related to Infanrix administration.
Went for a walk at lunch; started not feeling well. Dizzy, nauseated.  Gradual symptoms over next two weeks included fatigue, insomnia, headaches, shallow breathing, hot flashes (I had not had any in two years).
12/26/2020 1st Covid-19 vaccine Moderna 3pm Left arm 1/23/2021 2nd Covid-19 vaccine Moderna 3pm Left arm 6/18/2021 ill 6/22/2021 Covid PCR Positive 6/29/2021 potential to return to work
Had 2nd  shot on 3-5-2021 had reaction on 3-7-2021.  Have itch on arm and rash under the skin on going.  Called doctor he said to put Ice on it  and to take Benadryl
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: Gave patient water, a snack, and had him sit in pharmacy for full 30 minutes before leaving.  He said he felt perfectly fine and was having no other continuing symptoms.
Patient Asked to receive her Flu Vaccine, since her Husband was getting one at same visit. I had checked the system quickly and had not noted Flu Vaccine had been administered 9/9/2022. I administered the Vaccine. Then  noted that provider had ordered a BiValent COVID Booster to be given. I administered COVID Booster as ordered. When I went to Barcode the immunizations, I found that patient had had High Dose Flu Vaccine 9/9/2022. Patient tolerated Both Vaccines well and waited in Waiting room 15 minutes before going home. I informed APRN and Dr. of vaccine error. I was instructed by both providers to notify the patient. I called patient at her home and notified her. She stated that she felt fine and experienced no adverse effects. Patient instructed to notify our office with any problems or concerns.
injection site pain starting 6 hours after injection lasting 3 days  then no pain Injection site itching,  pain, redness (3inch diameter), tenderness, slight swelling on 1/29/21-- 9 days after injection improving with hot compresses and ibuprophen 11 days after injection but not cleared
Approx. 1 1/2 weeks after receiving, patients pupils became unequal.  Evaluation by pediatric ophthalmologist revealed no other pathological findings.  Dr. states that it was likely caused by a virus.  No neurological deficits noted.  MRI normal.  MD states that unequal pupils likely to be permanent but benign condition.
Rec'd flu immunization for first time.  Screened at employee flu clinic prior to immunization, which did not contraindicate giving flu vaccine.  Approx 2 hours later at home, c/o swelling tongue, increased dyspnea, "throat closing up"  After taking Albuterol inhaler without relief, took Benedryl, 911 called, transported to local ER.  Rec'd followup care for anaphylaxis.
1/22 started with chills, low fever, pain, burning sensation and swelling in both arms.  1/27 - pain and swelling continued, numbness of left hand. Evaluated in ER. Stated she received an anticoagulant, CK 2,500, liver enzymes elevated. 1/28 under the care of Dr. 180 Engle st Englewood. Dx. Rhabdomyolysis. treatment with aspirin, Cold compresses, fluids, and antibiotics if symptoms do not improve.  1/29 pain levels are improving, no antibiotics.  Employee expects to return to work on Sunday, 1/31.
Englarged lymph nodes in left armpit. Pain, swelling. Treatment - warm compress, no doctor's visits. Onset 8/17/2021 late in evening, has not subsided presently.
Narrative:  Patient reported experiencing low-grade fever, dizziness and nausea that resolved approximately 48 hours after vaccine administration
"I" started to feel really tired; Had a delusion of seeing balloons on the road; "I" started to feel nauseated; "I" slept for about 16-19 hours; This is a spontaneous report from a contactable nurse, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2088) via intramuscular route of administration in the left arm on 17Sep2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 21Aug2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via intramuscular route of administration in the right arm on 27Aug2021 at 19:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. In the morning on 18Sep2021 (saturday), the patient felt fine. After having lunch on 18Sep2021, the patient started to feel nauseated and about forty minutes after, she started to feel really tired and had a delusion of seeing balloons on the road. The patient's husband was driving in the car and she asked if he saw what she saw and he told no. Once they were home, the patient slept for about 16 to19 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "I" started to feel nauseated, "I" started to feel really tired and had a delusion of seeing balloons on the road was resolved on an unspecified date in Sep2021 while the clinical outcome of the event "I" slept for about 16-19 hours was resolved on 19Sep2021.